arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

USANA HEALTH SCIENCES INC

USNA
$14.04 ▼ -0.70 (-4.75%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
68 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

USANA HEALTH SCIENCES INC shows mixed fundamentals. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $259.5M
Dividend Yield
Revenue Growth -5.3%
Op. Margin -9.0%
ROIC -5.6%
FCF / Share $1.09
Trailing P/E
Price / Book 0.5x
FCF Yield 7.8%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$223.27M
↓ -5.3%
Net Income Profit after all expenses
$-21.38M
↓ -384.5%
Operating Margin Operating profit as % of sales
-9.0%
↓ -261.5% 40th
FCF / Share Free cash flow per share
$1.09
↑ +182.1%

Health Breakdown

Profitability
34
Returns
48
Financial Health
94
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters